Banminth 48

Manufacturer
Phibro Animal Health
Effective date
2025-03-10
Label type
OTC TYPE A MEDICATED ARTICLE ANIMAL DRUG LABEL
Version
10
Source
full-release
Hydrated at
2026-06-01 02:44:25

Label at a glance#

ProductBanminth 48
Active ingredientPYRANTEL
Label structure10 sections

Dosage and administration

Complete Swine Feeds Containing 0.0106% (96 g/t) Pyrantel Tartrate Amount of Banminth 48 per Ton of Complete Feed Resultant Use Level of PyranteTartrate in Complete Feed Indications for Use 16.67 lb 0.0881% (800g/t) For the removal and control of large roundworm (A. suum) and nodular worm (Oesophagostomum)infections in swine.† As a single therapeutic treatment in complete feed; feed at the rate 1 lb of feed per 40...

Label contents#

Full prescribing information#

DESCRIPTION SECTION

Swine Anthelmintic

Active Drug Ingredient:

DESCRIPTION SECTION

Pyrantel tartrate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10.6% (48 g/lb)

Indications for Use:

INDICATIONS & USAGE SECTION

For the removal and control of large roundworm (Ascaris suum) and nodular worm (Oesophagostomum)infections in swine.

Aid in the prevention of migration and establishment of large roundworm (A. suum) infections; aid in the prevention of establishment of nodular worm (Oesophagostomum)infections in swine.

For the removal and control of large roundworm (A. suum)infections in swine.

WARNING:

WARNINGS AND PRECAUTIONS SECTION

Withdraw 24 hours prior to slaughter.

Other Warning:Parasite resistance may develop to any dewormer. All dewormers require accurate dosing for best results. Following the use of any dewormer, effectiveness of treatment should be monitored. A decrease of effectiveness over time may indicate the ...

USE IN SPECIFIC POPULATIONS SECTION

For use in the manufacture of complete swine feeds and/or swine protein supplement feeds only.

CAUTION:

PRECAUTIONS SECTION

Certain components of animal feeds, including medicated premixes, possess properties that may be a potential health hazard or a source of personal discomfort to certain individuals who are exposed to them. Human exposure should, therefore, be minimized by observing the general industry standards for occupational health and safety.

Precautions such as the following should be considered: dust masks or respirators and protective clothing should be worn; dust-arresting equipment and adequate ventilation should be utilized; personal hygiene should be observed; wash before eating or leaving a work site; be alert for signs of allergic reactions–seek prompt medical treatment if such reactions are suspected.

MIXING AND USE DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

Complete Swine Feeds Containing 0.0106% (96 g/t) Pyrantel Tartrate

Amount of Banminth 48
per Ton of Complete Feed

Resultant Use Level of PyranteTartrate in Complete Feed

Indications for Use

16.67 lb

0.0881%
(800g/t)

For the removal and control of large roundworm (A. suum) and nodular worm (Oesophagostomum)infections in swine.†

Directions for Use

DOSAGE & ADMINISTRATION SECTION

As a single therapeutic treatment in complete feed; feed at the rate 1 lb of feed per 40 lb of body weight for animals up to 200 lb. For animals 200 lb or over, feed 5 lb of feed per head. Quantity of medicated feed required to treat pigs of various body weight is shown below:

Pig Weight (lb)

20

40

60

80

100

200 and over

Quantity of Feed per Pig

1/2 lb

1 lb

1 1/2 lb

2 lb

2 1/2 lb

5 lb

Fast pigs overnight for optimum results. Pigs will generally consume this quantity of medicated feed within a few hours time after which regular feeding should be resumed. Better worming is achieved when pigs are separated by size into different lots or pens for treatment. Water should be made available to animals during fasting and treatment periods.

Complete Swine Feeds Containing 0.0106% (96 g/t) Pyrantel Tartrate

Amount of Banminth 48
per Ton of Complete Feed

Resultant Use Level of Pyrantel Tartrate in Complete Feed

Indications for Use

Directions for Use

2 lb

0.0106%
(96 g/t)

Aid in the prevention of migration and establishment of large roundworm (A. suum) infections; aid in the prevention of establishment of nodular worm (Oesophagostomum) infections in swine.

Feed continuously as the sole ration

2 lb

0.0106%
(96 g/t)

For the removal and control of large roundworm (Ascaris suum) infections in swine.†

Feed for 3 days as the sole ration.

Swine Protein Supplements for Further Dilution to Feed Containing 0.0106% (96 g/t) Pyrantel Tartrate

Amount of Banminth 48
per Ton of Protein Supplement*

Indications for Use

Directions

To calculate the amount of Banminth 48 per ton of protein supplement, divide 4000 by the quantity (lb) of protein supplement that will be mixed with grain(s) to produce a ton of complete feed, that is:

4000 ÷ X = lb of Banminth 48 per ton of protein supplement.

where X = quantity (lb) of protein supplement that will be mixed with grain(s) to produce a ton of complete feed.

Example Calculation: Directions for use of the protein supplement require that 500 lb are to be mixed with grain(s) to produce a ton of complete feed.

4000 ÷ 500 = 8 lb of Banminth 48 per

ton of protein supplement.

Aid in the prevention of migration and establishment of large roundworm (A. suum)infections; aid in the prevention of establishment of nodular worm (Oesophagostomum) infections in swine.

Prepare a complete feed by mixing proper quantities of protein supplement with grain(s). If pelleted, grind pellets before or during mixing. The resultant complete feed contains 0.0106% (96 g/t) pyrantel tartrate and is to be fed continuously as the sole ration.

For the removal and control of large roundworm (A. suum) infections in swine.†

Prepare a complete feed by mixing proper quantities of protein supplement with grain(s). If pelleted, grind pellets before or during mixing. The resultant complete feed contains 0.0106% (96 g/t) pyrantel tartrate and is to be fed for 3 days as the sole ration.

Swine Protein Supplements for Further Dilution to Feed Containing 0.0881% (800 g/t) Pyrantel Tartrate

Amount of Banminth 48
per Ton of Protein Supplement*

Indications for Use

Directions for Use

To calculate the amount of Banminth 48 per ton of protein supplement, divide 33,333 by the quantity (lb) of protein supplement that will be mixed with grain(s) to produce a ton of complete feed, that is:

33,333 ÷ X = lb of Banminth 48 per ton of protein supplement.

where X = quantity (lb) of protein supplement that will be mixed with grain(s) to produce a ton of complete feed.

Example Calculation: Directions for use of the protein supplement require that 333 lb are to be mixed with grain(s) to produce a ton of complete feed.

33,333 ÷ 333 = 100 lb of Banminth 48 per ton of protein supplement.

For the removal and control of large roundworm (A. suum)and nodular worm (Oesophagostomum) infections in swine.†

Prepare a complete feed by mixing the proper quantities of protein supplement with grain(s). If pelleted, grind pellets before or during mixing. The resultant complete feed contains 0.0881% (800 g/t) pyrantel tartrate and is to be fed as sole ration for a single therapeutic treatment at the rate of 1 lb of feed per 40 lb of body weight for animals up to 200 lb. For animals 200 lb or over, feed 5 lb of feed per head. Fast pigs overnight for optimum results. Pigs will generally consume this quantity of medicated feed within a few hours time, after which regular feeding should be resumed. Better worming is achieved when pigs are separated by size into different lots or pens for treatment. Water should be made available to animals during fasting and treatment periods.

* To find grams of pyrantel tartrate, multiply lb of Banminth by 48.

† Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism.

WARNING:

WARNINGS SECTION

Withdraw 24 hours prior to slaughter.

CAUTION: Consult your veterinarian before using in severely debilitated animals.

Do not mix in feeds containing bentonite.

NOT FOR HUMAN USE

RESTRICTED DRUG (CALIFORNIA) – USE ONLY AS DIRECTED

SPL UNCLASSIFIED SECTION

SEE BACK OF PACKAGE FOR FURTHER USE DIRECTIONS

Banminth® 48 is a Phibro Animal Health Corporation registered trademark for Pyrantel Tartrate

Phibro Animal Health Corporation, Teaneck, NJ 07666.

Net Weight: 50 lb (22.7 kg)

Approved by FDA under NADA #043-290

7909000

101-9015-07

U.S. Patent No. 3,549,624

Made in USA

Banminth 48

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Banminth 48

LabelLabel

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
66104-2391-1Banminth 4822.7 kg in 1 BAGPOWDER22.710

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
66104-2391BANMINTH 48 (PYRANTEL TARTRATE) POWDER [PHIBRO ANIMAL HEALTH]101 package rows20250312_f09ef104-bf28-42a3-ac33-dc77d1c2b334.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
PYRANTELACTIVE INGREDIENT4QIH0N49E75
PYRANTELACTIVE MOIETY4QIH0N49E75
CALCIUM CARBONATEINACTIVE INGREDIENTH0G9379FGK5
MINERAL OILINACTIVE INGREDIENTT5L8T28FGP5
SOYBEANINACTIVE INGREDIENTL7HT8F1ZOD5

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
66104-239166104-2391-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 47 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
MINERAL OILMINERAL OILT5L8T28FGPTABLET, DELAYED RELEASE / ORAL5.67 mgExact identifier — unii candidate
30 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKTABLET, COATED / ORAL64.8 mgExact identifier — unii candidate
15 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPOINTMENT / AURICULAR (OTIC)NAExact identifier — unii candidate
30 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKTABLET, EXTENDED RELEASE / ORAL229.7 mgExact identifier — unii candidate
15 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPPASTE / DENTAL95 %w/wExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSUSPENSION / TOPICAL82 %w/wExact identifier — unii candidate
30 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKCAPSULE, DELAYED RELEASE / ORAL20 mgExact identifier — unii candidate
15 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPTABLET / ORAL113.75 mgExact identifier — unii candidate
30 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKTABLET, DELAYED RELEASE / ORAL8.4 mgExact identifier — unii candidate
15 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKSOLUTION / INTRAVENOUS4.02 %w/vExact identifier — unii candidate
15 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSYSTEM / TOPICAL654.36 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPTABLET, CHEWABLE / ORAL6 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPTABLET, FILM COATED / ORALNAExact identifier — unii candidate
30 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKGUM, CHEWING / BUCCAL3492 mgExact identifier — unii candidate
15 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKTABLET / ORAL793 mgExact identifier — unii candidate
15 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPFILM, EXTENDED RELEASE / TRANSDERMAL34 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPOINTMENT / OPHTHALMIC59.5 %w/wExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPTABLET, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
30 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKFILM, SOLUBLE / ORAL14 mgExact identifier — unii candidate
15 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPCAPSULE / ORAL120 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPPASTE / TOPICAL47.5 %w/wExact identifier — unii candidate
30 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKTABLET, CHEWABLE / ORAL1650 mgExact identifier — unii candidate
15 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSUPPOSITORY / RECTALNAExact identifier — unii candidate
30 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKCAPSULE, EXTENDED RELEASE / ORAL4 mgExact identifier — unii candidate
15 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKCAPSULE / ORAL349.9 mgExact identifier — unii candidate
15 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPLOTION / TOPICAL1428 mgExact identifier — unii candidate
30 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKSOLUTION / RESPIRATORY (INHALATION)4.02 %w/vExact identifier — unii candidate
15 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKPOWDER, DENTIFRICE / DENTAL0.5 mg/mgExact identifier — unii candidate
15 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSYSTEM / TRANSDERMAL6.09 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSPRAY / TOPICAL1379 mgExact identifier — unii candidate
30 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKSOLUTION / AURICULAR (OTIC)0.38 %w/wExact identifier — unii candidate
15 equally ranked IID candidates
SOYBEANSOYBEANL7HT8F1ZODEMULSION / TOPICAL3 %w/wExact identifier — unii candidate
2 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPCREAM / VAGINAL402 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPTABLET, COATED / ORAL1.5 mgExact identifier — unii candidate
30 equally ranked IID candidates
SOYBEANSOYBEANL7HT8F1ZODCAPSULE / ORALNAExact identifier — unii candidate
2 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPFILM / TRANSDERMAL11.42 mgExact identifier — unii candidate
30 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKTABLET, FILM COATED / ORAL300 mgExact identifier — unii candidate
15 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSUSPENSION / AURICULAR (OTIC)0.5 %w/vExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPOINTMENT / TOPICAL9938 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSUSPENSION / OPHTHALMIC0.1 %w/wExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSOAP / TOPICAL0.82 %w/wExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPCAPSULE, EXTENDED RELEASE / ORAL120 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSUPPOSITORY / VAGINAL30 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPOIL / TOPICAL43.29 %v/vExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPCREAM / TOPICAL2772 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPGEL / TOPICAL2.5 %w/wExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPDROPS / ORALNAExact identifier — unii candidate
30 equally ranked IID candidates

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.